Firefly Neuroscience, Inc., an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to announce its acquisition of Evoke Neuroscience, Inc. (“Evoke”), a medical device company developing and commercializing technologies to aid in the comprehensive assessment of brain health. The transaction marks another important step toward Firefly building a proprietary foundation model of the human brain using its FDA-cleared Brain Network Analytics (“BNA™”) technology.
Also Read: BrainChip Launches Edge AI Box Ecosystem
As a result of the acquisition, Firefly’s assets and business now include:
- The largest known proprietary database of >180,000 standardized, EEG/ERP assessment records
- 27 granted patents
- >60 current commercial users
These increases in propriety brain scans, patents and commercial sites represent greater than two-fold, three-fold and 10-fold expansions, respectively, as a result of the acquisition.
Source: Globenewswire
